Conduit Pharmaceuticals Inc. (CDT) Financials

$0.68

south_east
-$0 (-0.6%)
Day's range
$0.65
Day's range
$0.68

CDT Income statement / Annual

Last year (2024), CDT Equity Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, CDT Equity Inc.'s net income was -$17.80 M. See CDT Equity Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $457.00 K $0.00 $0.00 $0.00
Gross Profit -$457.00 K $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $3.38 M $90.00 K $111.00 K $283.00 K
General & Administrative Expenses $0.00 $5.17 M $3.05 M $2.89 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $11.58 M $5.17 M $3.05 M $2.89 M
Other Expenses $0.00 $0.00 $0.00 $0.00
Operating Expenses $14.96 M $5.26 M $3.16 M $3.17 M
Cost And Expenses $15.42 M $5.26 M $3.16 M $3.17 M
Interest Income $13.00 K $15.00 K $1.98 M $0.00
Interest Expense $1.51 M $211.00 K $0.00 $0.00
Depreciation & Amortization $457.00 K $0.00 $0.00 $0.00
EBITDA -$15.84 M $3.05 M -$4.89 M -$3.17 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net -$2.38 M $8.10 M -$1.73 M -$484.00 K
Income Before Tax -$17.80 M $2.84 M -$4.89 M -$3.66 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$17.80 M -$535.00 K -$4.89 M -$3.66 M
Net Income Ratio 0 0 0 0
EPS -20.53 -3.6 -0.0675 -1.01
EPS Diluted -20.53 -3.6 -0.0675 -1.01
Weighted Average Shares Out $2.03 M $1.67 M $3.62 M $576.15
Weighted Average Shares Out Diluted $2.06 M $1.70 M $3.62 M $576.15
Link